Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody–Positive Myasthenia Gravis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody–Positive Myasthenia Gravis

Published:2017-01-01 Issue:1 Volume:74 Page:60
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Robeson Kimberly R.¹,Kumar Aditya¹,Keung Benison¹,DiCapua Daniel B.¹,Grodinsky Emily²,Patwa Huned S.¹,Stathopoulos Panos A.¹,Goldstein Jonathan M.²,O’Connor Kevin C.¹,Nowak Richard J.¹

Affiliation:

1. Program in Clinical and Translational Neuromuscular Research, Division of Neuromuscular Medicine, Department of Neurology, Yale University School of Medicine, New Haven, Connecticut

2. Department of Neurology, Hospital for Special Surgery, New York, New York

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis;Journal of Neurology;2024-06-05

2. Exploring the depths of IgG4: insights into autoimmunity and novel treatments;Frontiers in Immunology;2024-04-18

3. Registered trials on novel therapies for myasthenia gravis: a cross-sectional study on ClinicalTrials.gov;Scientific Reports;2024-01-24

4. Therapeutic effect of ofatumumab in patients with myasthenia gravis: immunoregulation of follicular T helper cells and T helper type 17 cells;Frontiers in Neurology;2023-12-11

5. Rituximab treatment in myasthenia gravis;Frontiers in Neurology;2023-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP